# Converge Bio

**Canonical:** https://apis.io/providers/converge-bio/  
**Website:** https://converge-bio.com/  
**APIs profiled:** 0

Converge Bio is a generative-AI platform for life sciences that accelerates drug development across discovery, molecular design, and manufacturing. It trains Bio-LLM foundation models directly on biological languages (DNA, RNA, and protein sequences) and delivers them through the Converge Computational Lab, whose applications include ConvergeAB (AI antibody design across IgG/VHH/bispecific formats), ConvergeGEO (protein gene-expression optimization across CHO/HEK293/E. coli and other cell systems), ConvergeCELL (virtual cell simulation for target and biomarker discovery), and a Patent Extractor for mining antibody sequences. The platform is delivered to biotech and pharmaceutical customers under a Request Access engagement model; there is no public developer API, SDK, or self-serve documentation surface today. Backed by Bessemer Venture Partners ($25M Series A, January 2026); founded 2023.

## Kin Score — 11.5 / 100 (emerging)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 11.5).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 2.6 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Requires approval — onboarding: approval, pricing: unknown, trial: no (confidence: medium).

## Security (1)

- **Converge Bio Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Ai Ml, Drug Discovery, Generative AI, Biotech, Pharmaceuticals, Antibody Design, Genomics, Life Sciences, Machine-Learning

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/converge-bio/). Scores are computed from the provider's own public artifacts under a published rubric.